Condensed Consolidated Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | 9 Months Ended | 12 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2022 |
Jun. 30, 2022 |
Sep. 30, 2021 |
Jun. 30, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
Dec. 31, 2020 |
Sep. 30, 2022 |
Sep. 30, 2021 |
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| Operating loss | $ (6,045,830) | $ (1,073,490) | $ (11,256,395) | $ (5,104,596) | $ (6,519,918) | $ (8,737,057) | |||||
| Other expense (income) | |||||||||||
| Other income, net | (234,597) | 1,140 | (239,838) | (1,573,748) | (1,601,568) | (1,609,962) | |||||
| Loss on extinguishment of debt | 9,484,113 | ||||||||||
| Interest expense, net | 1,402,026 | 223,492 | 3,057,660 | 361,867 | 725,166 | 66,943 | |||||
| Total other (income) expense, net | 37,840 | 224,632 | 1,688,233 | (1,211,881) | 8,607,711 | (1,543,019) | |||||
| Change in fair value of warrant liabilities | (1,129,589) | (1,129,589) | |||||||||
| Net income (loss) | $ (6,083,670) | $ (3,356,956) | $ (1,298,122) | $ (1,074,911) | $ (12,944,628) | $ (3,892,715) | $ (15,127,629) | $ (7,194,038) | |||
| Basic and diluted weighted average shares outstanding (in Shares) | 678,406 | 678,400 | |||||||||
| Diluted weighted average shares outstanding (in Shares) | 16,535,661 | 9,637,962 | 11,983,183 | 9,637,962 | 678,406 | 678,400 | |||||
| Service | $ 2,964,610 | $ 1,844,422 | $ 7,996,734 | $ 2,799,113 | $ 7,854,068 | $ 3,184,629 | |||||
| Product | 242,637 | ||||||||||
| Service – related party | 17,000 | 129,222 | 210,400 | 446,600 | 332,767 | 619,883 | |||||
| Product – related party | 162,068 | 189,928 | |||||||||
| Cost of revenue (exclusive of items shown separately below) | 3,781,224 | 1,446,979 | 8,220,447 | 3,609,236 | 6,850,248 | 4,059,991 | |||||
| Depreciation and amortization | 141,901 | 88,531 | 370,306 | 263,032 | 365,097 | 400,432 | |||||
| Research and development | 242,996 | 741,558 | 2,094,278 | 2,411,100 | 3,533,713 | 4,951,619 | |||||
| General and administrative | $ 4,861,319 | $ 770,066 | $ 8,778,498 | $ 2,066,941 | $ 4,362,400 | $ 3,319,455 | |||||
| Basic net income (loss) per share of common stock (in Dollars per share) | $ (22.3) | $ (10.6) | |||||||||
| Diluted earnings (loss) per share (in Dollars per share) | $ (0.67) | $ (0.13) | $ (1.49) | $ (0.4) | $ (22.3) | $ (10.6) | |||||
| Revenue | |||||||||||
| Total revenue | $ 2,981,610 | $ 1,973,644 | $ 8,207,134 | $ 3,245,713 | $ 8,591,540 | $ 3,994,440 | |||||
| Costs and Expenses | |||||||||||
| Total costs and expenses | $ 9,027,440 | $ 3,047,134 | $ 19,463,529 | $ 8,350,309 | 15,111,458 | $ 12,731,497 | |||||
| CleanTech Acquisition Corp | |||||||||||
| Operating costs | 1,446,459 | $ 1,905,106 | $ 1,000 | 1,201,383 | |||||||
| Franchise tax expense | 76,033 | 96,761 | 97,200 | ||||||||
| Operating loss | (1,522,492) | (2,001,867) | (1,000) | (1,298,583) | |||||||
| Other expense (income) | |||||||||||
| Transaction costs allocated to warrant liabilities | (155,037) | ||||||||||
| Net gain on investments held in Trust Account | 235,270 | 252,815 | 5,428 | ||||||||
| Gain on change in fair value of warrant liabilities | 503,750 | 2,917,250 | |||||||||
| Income (loss) before income taxes | (783,472) | 1,168,198 | |||||||||
| Income taxes | (12,359) | (12,359) | |||||||||
| Change in fair value of warrant liabilities | 1,077,750 | ||||||||||
| Change in fair value of over-allotment option liability | (225,000) | ||||||||||
| Net income (loss) | $ (795,831) | $ 1,155,839 | $ (1,000) | $ (595,442) | |||||||
| Basic and diluted weighted average shares outstanding (in Shares) | 21,562,500 | 3,750,000 | 21,562,500 | 3,750,000 | 3,750,000 | 11,781,678 | |||||
| Basic net income (loss) per share of common stock (in Dollars per share) | $ (0.04) | $ 0 | $ 0.05 | $ 0 | $ 0 | $ (0.05) | |||||
| X | ||||||||||
- Definition The amount of gain on change in fair value of warrant liabilities. No definition available.
|
| X | ||||||||||
- Definition Product – related party. No definition available.
|
| X | ||||||||||
- Definition Revenue from product. No definition available.
|
| X | ||||||||||
- Definition Warrant issuance costs. No definition available.
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate costs incurred that are directly related to activities, including but not limited to, generating franchise revenues from franchisor owned outlets and franchised outlets. No definition available.
|
| X | ||||||||||
- Definition Amount of realized and unrealized gain (loss) on investment. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The net amount of operating interest income (expense). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense. No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|